---
title: "Millicom International Cellular S.A. Stock 12‑Month Price Target Raised to $90.34, Implies 2% Downside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295155258.md"
description: "Millicom International Cellular S.A.'s average 12-month price target was raised to $90.34 by seven analysts, up from $89.63. Based on the August 5 closing price, this implies a 2% downside. The consensus rating remains 'Hold' among eight covering analysts, comprising three buys, three holds, and two sells."
datetime: "2026-08-06T23:20:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295155258.md)
  - [en](https://longbridge.com/en/news/295155258.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295155258.md)
---

# Millicom International Cellular S.A. Stock 12‑Month Price Target Raised to $90.34, Implies 2% Downside

-   According to estimates from 7 analysts, Millicom International Cellular S.A. stock's average price target has risen from $89.63 to $90.34, with forecasts ranging from $52.4 to $105 per share
-   Based on the Aug. 5 closing price, the updated target implies approximately 2% potential downside
-   Consensus rating remains at “Hold” across 8 covering analysts, with 3 Buys, 3 Holds and 2 Sells

Explore more price target data and ratings for Millicom International Cellular S.A. on the , and track all previous and future analyst recommendations for Millicom International Cellular S.A. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [TIGO.US](https://longbridge.com/en/quote/TIGO.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Convening Notice for Annual General Meeting of Shareholders | TIGO Stock News](https://longbridge.com/en/news/280528189.md)
- [Do Fastenal’s (FAST) Mixed Reactions to Solid Revenue Hint at Limits of Its Digital Strategy?](https://longbridge.com/en/news/295686937.md)
- [Ralph Lauren (RL) Beat First Quarter Estimates, Is The Upside Already Priced In?](https://longbridge.com/en/news/295837110.md)
- [CONMED (CNMD) Could Be 8% Overvalued Following Its Recent Rebound](https://longbridge.com/en/news/296318744.md)
- [Should FDA Clearance Of QIAstat-Dx Sepsis Panel Require Action From Qiagen (QGEN) Investors?](https://longbridge.com/en/news/296027748.md)